Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

INTRODUCTION: Ankylosing spondylitis (AS) is a chronic rheumatic disease associated with spinal inflammation that subsequently leads to progression of structural damage and loss of function. The fully human anti-tumor necrosis factor (anti-TNF) antibody adalimumab reduces the signs and symptoms and...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijde, Désirée, Salonen, David, Weissman, Barbara N, Landewé, Robert, Maksymowych, Walter P, Kupper, Hartmut, Ballal, Shaila, Gibson, Eric, Wong, Robert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745811/
https://www.ncbi.nlm.nih.gov/pubmed/19703304
http://dx.doi.org/10.1186/ar2794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745811/
https://www.ncbi.nlm.nih.gov/pubmed/19703304
http://dx.doi.org/10.1186/ar2794

Ejemplares similares